This article covers a fundraising round on 30 September 2025 by NoBACZ, a University of Cambridge spinout developing liquid bandage woundcare for horses and livestock, founded by Dr Jonathan Powell and Dr Nuno Faria. The company raised £4.8m in a round led by The Yield Lab, with participation from Adjuvo.
NoBACZ produces a liquid bandage for veterinary wound care in livestock and horses. It provides a topical barrier to seal and protect wounds, reducing contamination and the need for cloth bandages.
People caring for farm animals face persistent wound infections like digital dermatitis that resist topical antibiotics and contaminated cloth bandages.
NoBACZ explains that it makes a liquid bandage that seals wounds, reduces antibiotic use and prevents contamination in farm environments.
NoBACZ secured £4.8m in a funding round led by The Yield Lab, with participation from Adjuvo alongside existing backers. This makes it the 36th largest funding round in September 2025 (60 recorded). It ranks 216th of the year (467 recorded) in the Startupmag database, as of 30 September 2025.
For details on how Startupmag compiles its rankings, view our Methodology.
Key investors in the financing included:
In the funding announcement, Mark Foster-Brown from Adjuvo said:
For too long, topical antibiotics and bandages have offered inadequate solutions for animal wound care. NoBACZ's patented platform technology sets a new benchmark, delivering ground-breaking results while aligning with Adjuvo's mission to back innovation in underserved sectors.
If you're researching potential backers in this space:
The founders of NoBACZ are Dr Jonathan Powell and Dr Nuno Faria.
In the funding announcement, Dr Jonathan Powell, chief executive of NoBACZ said:
We founded NoBACZ Healthcare with the goal of transforming healthcare solutions for a more sustainable future whilst reducing antibiotic use. This new funding will fuel our expansion as we broaden our global product reach, launch our new range of products for the equine industry and continue to develop innovative veterinary healthcare solutions.
The company continued that in addition to its pipeline of veterinary products it was starting to define its human product opportunity.
NoBACZ is based in Cambridge, UK.
NoBACZ operates in the Healthtech sector. Healthtech develops technologies and products to prevent, diagnose or treat health problems.
Key trends and challenges in Animal health:
Pressure to cut antibiotic use is rising to fight resistance; digital dermatitis affects about 25% of dairy cows.
Farmers and vets seek non-antibiotic topical solutions, such as liquid bandages, for wounds in cattle and horses.
Dirty barn conditions make traditional bandages ineffective and infection risk remains high, complicating treatment.
For a deeper look at innovation in this space, see the latest funded Healthtech startups in the UK
Investor | Sector | Stage | Activity | Team | Connect |
---|---|---|---|---|---|
![]() The Yield Lab | 1 investment(s) investment(s) | more info | |||
![]() Adjuvo | 8 investment(s) investment(s) | more info | |||
![]() ACFInvestors (ACF Investors) | 10 investment(s) investment(s) | 3 contacts contacts | |||
![]() Parkwalk | 4 investment(s) investment(s) | more info | |||
![]() The FSE Group | 4 investment(s) investment(s) | 9 contacts contacts |
Click here for a full list of 7,233+ startup investors in the UK